Related Experiment Video
Updated: Dec 7, 2025

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Niclosamide activates the AMP-activated protein kinase complex containing the β2 subunit independently of AMP
Tsukasa Suzuki1, Momoko Kojima1, Yu Matsumoto1
1Department of Agricultural Chemistry, Faculty of Applied Biosciences, Tokyo University of Agriculture, Setagaya-ku, Tokyo, 156-8502, Japan.
Abstract:
AMP-activated protein kinase (AMPK) regulates cellular energy homeostasis by suppressing anabolic processes and activating catabolic processes. AMPK activators are an important therapeutic target for metabolic syndrome due to favorable physiological effects of AMPK activation on metabolism. Recent studies show that niclosamide, an FDA-approved anthelmintic drug that exerts an uncoupling effect on the mitochondria of the parasite, improves blood glucose levels and reduces hepatic steatosis in mice via AMPK activation. Niclosamide is thought to activate AMPK by increasing AMP/ATP ratio through mitochondrial uncoupling, but details of its action remain unclear. In this study, we found that niclosamide also activates the AMPK complex, which contains the AMP-insensitive γ subunit. Further, niclosamide shows greater AMPK activation for the AMPK complex containing β2 subunit, but not the β1 subunit. This effect was inhibited by substituting the Ser108 residue of the β2 subunit to alanine. Niclosamide displays a novel AMPK activation mechanism independent of the increase in AMP/ATP ratio.
Insights
Niclosamide activates AMP-activated protein kinase (AMPK) through a novel mechanism. This FDA-approved drug targets the AMPK complex
Area of Science:
- Biochemistry
- Cellular Metabolism
- Pharmacology
Background:
- AMP-activated protein kinase (AMPK) is crucial for cellular energy homeostasis, making it a therapeutic target for metabolic syndrome.
- Niclosamide, an anthelmintic drug, has shown potential in improving glucose levels and reducing hepatic steatosis through AMPK activation.
- The precise mechanism by which niclosamide activates AMPK, particularly its interaction with mitochondrial uncoupling, requires further elucidation.
Purpose of the Study:
- To investigate the detailed mechanism of AMPK activation by niclosamide.
- To determine if niclosamide's action is dependent on the AMP/ATP ratio.
- To identify specific subunits and residues involved in niclosamide-mediated AMPK activation.
Main Methods:
- Biochemical assays to measure AMPK activity in response to niclosamide.
- Analysis of AMPK complex composition, focusing on different beta subunits (β1 and β2).
- Site-directed mutagenesis of the β2 subunit (Ser108) to assess its role in niclosamide's effect.
Main Results:
- Niclosamide activates the AMPK complex, including the AMP-insensitive γ subunit.
- AMPK activation by niclosamide is enhanced with the β2 subunit compared to the β1 subunit.
- Mutation of Ser108 in the β2 subunit abrogated niclosamide-induced AMPK activation.
- Niclosamide activates AMPK independently of changes in the cellular AMP/ATP ratio.
Conclusions:
- Niclosamide employs a novel mechanism to activate AMPK, distinct from increasing the AMP/ATP ratio.
- The β2 subunit, specifically Ser108, plays a critical role in niclosamide's AMPK activation pathway.
- These findings offer new insights into AMPK regulation and the therapeutic potential of niclosamide for metabolic disorders.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades